NBE-Landing Page NBE-Landing Page

Accelerate your large molecule discovery programme

with world-class discovery services

Speak to our Expert

The Aurigene expertise

Aurigene Pharmaceutical Services offers an extensive array of discovery and development services for New Biological Entities (NBEs) through a state-of-the-art facility located in Hyderabad, India. Our large molecule discovery services are driven by the expertise of a talented team of scientists who are highly experienced in developing and delivering various advanced therapeutic modalities, including monoclonal antibodies, antibody-drug conjugates, bispecific antibodies, protein therapeutics, mRNA, and CAR-T. We develop and adopt innovative technology platforms for faster, reliable and cost-effective solutions to complex problems throughout the biologics value chain. We also specialize in forward integrating large molecule discovery with clinical manufacturing and beyond.

Aurigene Pharmaceutical

Our Large Molecule Discovery services include

in-vitro Biology
and Screening

Our in vitro biology and screening division offers a wide spectrum of biochemical and cell-based assays to profile small and large molecule entities.

Molecular Biology

Offering a vast range of services in the areas of recombinant DNA technology, antibody gene sequencing, mutagenesis, library generation, plasmid DNA preparation, microbial genome engineering, gene expression analysis and IVT mRNA synthesis.

mRNA Synthesis

We have industry-leading expertise in high-quality, customized and scalable mRNA synthesis by in vitro transcription.

Research Model

We have world-class expertise in conducting Zebrafish research (Danio rerio) models for drug discovery studies and screening of chemical compounds

Antibody Discovery

All our antibody discovery programmes are designed with the therapeutic endpoint in mind, while the technology platform is selected accordingly. Our team has extensive experience in handling several technology platforms, such as humanized rodents, B-cell cloning, hybridoma, and display libraries.

Antibody Drug
Conjugate Services

Our talented ADC team is well experienced in a wide range of ADC technologies and is capable of adopting new technologies to support our clients' needs


Offering a comprehensive suite of services to support stages from sequence optimization to final product generation (Gene to Protein)

Protein Crystallography
and Structural Biology

Offering a one-stop solution for determining 3D structure of proteins, protein-protein complexes, protein-small molecule complexes, and antibody-antigen complexes at high resolution through world-class protein crystallography services

Cell Line Engineering
and Development

Cell engineering services at Aurigene cater to both tool/reagent and biological product development requirements. We have strong expertise in generating recombinant/stable cell lines for complex and wide protein class targets.

Why Aurigene Services?

18 years
of expertise

Experience gained
from 100+ discovery


Track record
of delivering
8+ IND candidates

Flexible working


Capabilities to
apply multiple

Seamless integration
capabilities with
Biology as well as
CDMO services


Expertise in
various therapeutic

Contact Us

CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

© 2022 Aurigene Pharmaceutical Services Ltd. | All rights reserved.


You are about to leave Aurigene Pharmaceutical Services and affiliates website. Aurigene Pharmaceutical Services assumes no responsibility for the information presented on the external website or any further links from such sites. These links are presented to you only as a convenience, and the inclusion of any link does not imply endorsement by Aurigene Pharmaceutical Services.

If you wish to continue to this external website, click Proceed.